LiminalX and Rayos Contra Cancer Partner to bring AI Readiness Awareness to Radiation Oncology Teams Worldwide

ATLANTA, Oct. 13, 2026 /PRNewswire/ -- LiminalX, a healthcare AI readiness company based in Atlanta, and Rayos Contra Cancer (RCC), a nonprofit that delivers radiation oncology education around the world, have signed an agreement to integrate the THRIVE platform into RCC's educational courses.

Under the agreement, LiminalX will provide RCC and its course participants access to the Human Dimension of its THRIVE Platform. The goal is to raise awareness of artificial intelligence in healthcare and help clinical staff prepare for its responsible use, especially in the regions where RCC is most active.

AI solutions are entering clinical workflows at a pace that challenges teams to build their knowledge to evaluate and use them efficiently, with confidence. THRIVE gives clinicians a structured way to assess their readiness across six dimensions: Technical, Human, Regulatory, Infrastructure, Value and Evaluation. Under the Human Dimension, each participant gets a Human Readiness Level (HRL) score and a clear view of where to focus their learning, personally or at their organization level.

Built into RCC's courses, THRIVE will help participants:

• Build a shared vocabulary for discussing AI in clinical practice
• Identify their own behavioural strengths and gaps in AI readiness
• Approach new AI tools with informed, critical judgment

"RCC's mission is to empower clinicians in limited-resource settings with the knowledge and tools to deliver equitable, high-quality care for their patients," said Benjamin Li, MD, MBA, Founder and Executive Director of Rayos Contra Cancer. "As Artificial Intelligence becomes increasingly present in our lives and clinical environments, it makes sense that we should have a common framework for understanding our experience and relationship with its use. LiminalX has worked with experts to develop professional psychometrics that can help unify our field as we prepare for a future with heavy AI-integration. We're honored that we can make this opportunity for self-assessments available for the clinics and clinicians that we serve, so that we can be proactive rather than reactive to changes coming from rapid technological advances."

"We are thrilled to support RCC in their work empowering underserved communities where the safe use of AI has the potential to transform access and quality of care," said Paul Naine, Founder, LiminalX.

The partnership reflects a shared belief that preparing for AI should not depend on geography or resources. Clinical teams everywhere deserve the knowledge to adopt new technology safely and with confidence.

To learn more about RCC's courses, visit https://www.rayoscontracancer.org. To learn more about THRIVE, visit https://liminal-x.ai.

Media Contact

Phil Fortier
Commercial Lead, LiminalX
[email protected]
+1-514-518-1861

SOURCE LiminalX